Your browser doesn't support javascript.
loading
Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study.
Krzemien, Pawel; Kasperczyk, Slawomir; Banach, Maciej; Kasperczyk, Aleksandra; Dobrakowski, Michal; Tomasik, Tomasz; Windak, Adam; Mastej, Miroslaw; Catapano, Alberico; Ray, Kausik K; Mikhailidis, Dimitri P; Toth, Peter P; Howard, George; Lip, Gregory Y H; Tomaszewski, Maciej; Charchar, Fadi J; Sattar, Naveed; Williams, Bryan; MacDonald, Thomas M; Penson, Peter E; Józwiak, Jacek J.
Affiliation
  • Krzemien P; Euroimmun Polska Sp. z o.o., 2a Widna St., 50-543, Wroclaw, Poland. p.krzemien@euroimmun.pl.
  • Kasperczyk S; Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
  • Banach M; Department of Hypertension, Medical University of Lodz, Lódz, Poland. maciej.banach@icloud.com.
  • Kasperczyk A; Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
  • Dobrakowski M; Department of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
  • Tomasik T; Department of Family Medicine, Jagiellonian University Medical College, Kraków, Poland.
  • Windak A; Department of Family Medicine, Jagiellonian University Medical College, Kraków, Poland.
  • Mastej M; Mastej Medical Center, Jaslo, Poland.
  • Catapano A; Department of Pharmacological Sciences, University of Milano and Multimedica IRCCS, Milan, Italy.
  • Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College, Kensington, London, UK.
  • Mikhailidis DP; Department of Clinical Biochemistry, Royal Free Hospital, University College London, London, UK.
  • Toth PP; Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Howard G; CGH Medical Center, Sterling, IL, USA.
  • Lip GYH; Department of Biostatistics, School of Public Health of Alabama, Birmingham, AL, USA.
  • Tomaszewski M; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, UK.
  • Charchar FJ; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Sattar N; Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Williams B; School of Health and Life Sciences, Federation University Australia, Ballarat, VIC, Australia.
  • MacDonald TM; Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, UK.
  • Penson PE; NIHR University College London Biomedical Research Centre, University College London and University College London Hospitals NHS Foundation Trust, London, UK.
  • Józwiak JJ; MEMO Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK.
Rheumatol Int ; 42(2): 261-271, 2022 02.
Article in En | MEDLINE | ID: mdl-34755204
ABSTRACT
The detection of antinuclear autoantibody (ANA) is dependent on many factors and varies between the populations. The aim of the study was first to assess the prevalence of ANA in the Polish adult population depending on age, sex and the cutoff threshold used for the results obtained. Second, we estimated the occurrence of individual types of ANA-staining patterns. We tested 1731 patient samples using commercially available IIFA using two cutoff thresholds of 1100 and 1160. We found ANA in 260 participants (15.0%), but the percentage of positive results strongly depended on the cutoff level. For a cutoff threshold 1100, the positive population was 19.5% and for the 1160 cutoff threshold, it was 11.7%. The most prevalent ANA-staining pattern was AC-2 Dense Fine speckled (50%), followed by AC-21 Reticular/AMA (14.38%) ANA more common in women (72%); 64% of ANA-positive patients were over 50 years of age. ANA prevalence in the Polish population is at a level observed in other highly developed countries and is more prevalent in women and elderly individuals. To reduce the number of positive results released, we suggest that Polish laboratories should set 1160 as the cutoff threshold.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Antibodies, Antinuclear Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Rheumatol Int Year: 2022 Document type: Article Affiliation country: Poland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Antibodies, Antinuclear Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Rheumatol Int Year: 2022 Document type: Article Affiliation country: Poland